Search - tctmd.com

Displaying 341 - 360 of 497

Sort: Relevancy | Date

News Conference News HRS 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

Todd Neale

May 13, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Features

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Yael L. Maxwell

March 24, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Opinion Editor's Corner

COVID-19 and the Heart: Insights From the Front Lines

Shelley Wood

March 12, 2020

News Daily News

Stick-on Sensor Predicts Heart-Failure Hospitalizations: Pilot Study

Shelley Wood

February 26, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Conference News AHA 2019

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

Shelley Wood

November 22, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

Presentation TCT 2019

Direct Sodium Removal With an Ambulatory Peritoneal Dialysis System: Sequana

Presenter: Jeffrey Testani

September 28, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

Advertisement

Subcutaneous ICD Holds Up Well Against Transvenous Devices

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Missed Opportunities: Many HF Patients Not Tested for CAD

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

COVID-19 and the Heart: Insights From the Front Lines

Stick-on Sensor Predicts Heart-Failure Hospitalizations: Pilot Study

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

TCTMD’s Top 10 Most Popular Stories for October 2019

Direct Sodium Removal With an Ambulatory Peritoneal Dialysis System: Sequana

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content